Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 2/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.33 |
| ▸ | IDH1 | O75874 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | CTSA | P10619 | 2/20 | 0.31 |
| ▸ | CFB | P00751 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3672714 | 0.90 | IDH1 (0.32) | IDH1 | |
| SCHEMBL3670065 | 0.86 | TAAR1 (0.38) | ADRA2AADRA1ATAAR1CFB | |
| SCHEMBL3669311 | 0.84 | CFB (0.36) | ADRA2AADRA1ATAAR1CTSACFB | |
| SCHEMBL3668500 | 0.80 | CFB (0.35) | ADRA2AADRA1ATAAR1CFB | |
| SCHEMBL3673071 | 0.79 | ADRA2A (0.47) | ADRA2AADRA1ATAAR1 | |
| SCHEMBL1157005 | 0.76 | GRIN1 (0.35) | ADRA2AADRA1AIDH1TAAR1CTSA | |
| SCHEMBL3671320 | 0.76 | TAAR1 (0.40) | ADRA2AADRA1ATAAR1CTSA | |
| SCHEMBL3673459 | 0.73 | P2RX7 (0.41) | CFB | |
| SCHEMBL3411857 | 0.73 | CFB (0.36) | ADRA2AADRA1ATAAR1CFB | |
| SCHEMBL3804488 | 0.72 | TAAR1 (0.40) | ADRA2AADRA1ATAAR1CTSACFB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2242753-A1 | OXAZOLIDINE AND THIAZOLIDINE SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF | ALLERGAN, INC. (US) | 2010-10-27 | — | — | EP | disclosed |
| EP-2240468-A1 | SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF | ALLERGAN, INC. (US) | 2010-10-20 | — | — | EP | disclosed |
| WO-2009091759-A1 | SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF | ALLERGAN, INC. (US) | 2009-07-23 | — | — | WO | disclosed |
| WO-2009091760-A1 | OXAZOLIDINE AND THIAZOLIDINE SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF | ALLERGAN, INC. (US) | 2009-07-23 | — | — | WO | disclosed |